IL6 and breast carcinoma: In breast cancer, ZEB1 promotes inflammation in the tumor microenvironment by regulating the secretion of the proinflammatory cytokines interleukin 6 (IL-6) and IL-8 and subsequently inducing the growth of fibroblasts and myeloid-derived suppressor cells [39].